Initialization of adjuvant hormonal treatment for breast cancer-Reference-Cited by-同舟云学术

Initialization of adjuvant hormonal treatment for breast cancer

Published:2011-09 Issue:S6 Volume:28 Page:66-84
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Therapy

Author:

Martínez Guisado Antonia,Sánchez Muñoz Alfonso,de la Cabeza Lomas Garrido María,Ruíz Borrego Manuel,Bayo Calero Juan,de Toro Salas Rubén,González Mancha R.,de la Haba Rodríguez Juan,Alba Conejo Emilio

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-011-0039-8.pdf

Reference36 articles.

1. Arimidex, TAM, Alone or in Combination (ATAC) Trialists’ Group, Forbes JF, Cuzick J, Buzdar A, et al. Effect of anastrozole and TAM as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol. 2008;9:45–53.

2. The BIG 1-98 Collaborative Group. Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. N Engl J Med. 2005;353:2747–2757.

3. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–1717.

4. Coates AS, Keshaviah A, Thurlimann B, et al. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol. 2007;25:486–492.

5. Coombes RC, Kilburn LS, Snowdon CF, et al. Survival and safety of exemestane versus tamoxifen after 2–3 years’ tamoxifen treatment (Intergroup Exemestane Study): a randomized controlled trial. Lancet. 2007;369:559–570.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial;Breast Cancer Research;2023-04-14

2. Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole;OncoTargets and Therapy;2016-10

3. Sodium tungstate modulates ATM function upon DNA damage;FEBS Letters;2013-04-12

4. Malignant Breast Tumors;Geriatric Imaging;2013

5. Comparison of immunohistochemical analysis with estrogen receptor SP1 and 1D5 monoclonal antibodies in breast cancer;Pathology - Research and Practice;2012-11